Detalles de la búsqueda
1.
Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial.
Lancet Oncol
; 25(1): 99-107, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38043558
2.
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.
Lancet
; 397(10276): 797-804, 2021 02 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33581798
3.
Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases.
Br J Cancer
; 116(12): 1558-1563, 2017 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28524161
4.
Cessation of targeted therapy after a complete response in BRAF-mutant advanced melanoma: a case series.
Br J Cancer
; 115(11): 1280-1284, 2016 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27711085
5.
Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients.
BMC Cancer
; 16: 124, 2016 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-26892430
6.
Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: Results from the final analysis of the randomized phase 2 Basal Cell Carcinoma Outcomes With LDE225 Treatment (BOLT) trial at 42 months.
J Am Acad Dermatol
; 84(4): 1162-1164, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33358380
7.
Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors.
Cancer
; 121(21): 3826-35, 2015 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26218930
8.
Patient outcomes following a response biomarker-guided approach to treatment using 177Lu-PSMA-I&T in men with metastatic castrate-resistant prostate cancer (Re-SPECT).
Ther Adv Med Oncol
; 15: 17588359231156392, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36872949
9.
Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical Review.
Front Oncol
; 11: 706331, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34604043
10.
Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer.
Radiother Oncol
; 90(2): 172-6, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18976827
11.
Results of a Prospective Phase 2 Pilot Trial of 177Lu-PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer Including Imaging Predictors of Treatment Response and Patterns of Progression.
Clin Genitourin Cancer
; 17(1): 15-22, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30425003
12.
An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system.
Eur J Cancer
; 107: 175-185, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30580112
13.
Cabazitaxel in patients with metastatic castration-resistant prostate cancer: safety and quality of life data from the Australian early access program.
Asia Pac J Clin Oncol
; 13(6): 391-399, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28488360
14.
Residual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapy.
Pigment Cell Melanoma Res
; 29(5): 572-7, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27333363
15.
Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review.
Oral Oncol
; 53: 10-6, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26712252
16.
Neutrophil-to-lymphocyte ratio in head and neck cancer.
J Med Imaging Radiat Oncol
; 59(4): 514-519, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25908427
17.
Pembrolizumab for cutaneous squamous cell carcinoma: Report of a case of inoperable squamous cell carcinoma with complete response to pembrolizumab complicated by granulomatous inflammation.
JAAD Case Rep
; 5(6): 491-494, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31193588
18.
Intensity-modulated radiotherapy using simultaneous-integrated boost for definitive treatment of locally advanced mucosal head and neck cancer: outcomes from a single-institution series.
J Med Imaging Radiat Oncol
; 57(3): 356-63, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23721147
19.
Acute Radiation Skin Toxicity Associated With BRAF Inhibitors.
J Clin Oncol
; 34(3): e17-20, 2016 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24868021
Resultados
1 -
19
de 19
1
Próxima >
>>